Skip to Content
  • Previous Rank473
  • Revenues ($M)$6,710.8
  • Revenue Percent Change14.3%
  • Profits ($M)$2,444.4
  • Profits Percent Change104.0%
  • Assets ($M)$11,734.5
  • Employees7,400

The biopharmaceutical company develops and manufactures medicines concerning a range of illnesses, including asthma, pain, cancer, and infectious diseases.

Fortune Data StoreLooking for leads, investment insights, or competitive intelligence?Get Premium Access

Company Info

Leonard S. Schleifer
CEO Title
President, Chief Executive Officer & Director
Health Care
HQ Location
Tarrytown, N.Y.
Years on Fortune 500 List2

Regeneron Pharmaceuticals Rank History

Key Financials (Last Fiscal Year)

$ millions% change
Revenues ($M)$6,710.814.3%
Profits ($M)$2,444.4104.0%
Assets ($M)$11,734.5-
Total Stockholder Equity ($M)$8,757.3-

Profit Ratios

Profit as % of Revenues36.4%
Profits as % of Assets20.8%
Profits as % of Stockholder Equity27.9%

Earnings Per Share (Last Fiscal Year)

Earnings Per Share ($)21.29
EPS % Change (from 2017)105.9%
EPS % Change (5 year annual rate)41.8%
EPS % Change (10 year annual rate)-

Total Return

Total Return to Investors (2018)-0.7%
Total Return to Investors (5 year, annualized)6.3%
Total Return to Investors (10 year, annualized)35.2%